Literature DB >> 17456598

Distinct functional motifs within the IL-17 receptor regulate signal transduction and target gene expression.

Amarnath Maitra1, Fang Shen, Walter Hanel, Karen Mossman, Joel Tocker, David Swart, Sarah L Gaffen.   

Abstract

IL-17 is the founding member of a novel family of proinflammatory cytokines that defines a new class of CD4+ effector T cells, termed "Th17." Mounting evidence suggests that IL-17 and Th17 cells cause pathology in autoimmunity, but little is known about mechanisms of IL-17RA signaling. IL-17 through its receptor (IL-17RA) activates genes typical of innate immune cytokines, such as TNFalpha and IL-1beta, despite minimal sequence similarity in their respective receptors. A previous bioinformatics study predicted a subdomain in IL-17-family receptors with homology to a Toll/IL-1R (TIR) domain, termed the "SEFIR domain." However, the SEFIR domain lacks motifs critical for bona fide TIR domains, and its functionality was never verified. Here, we used a reconstitution system in IL-17RA-null fibroblasts to map functional domains within IL-17RA. We demonstrate that the SEFIR domain mediates IL-17RA signaling independently of classic TIR adaptors, such as MyD88 and TRIF. Moreover, we identified a previously undescribed"TIR-like loop" (TILL) required for activation of NF-kappaB, MAPK, and up-regulation of C/EBPbeta and C/EBPdelta. Mutagenesis of the TILL domain revealed a site analogous to the LPS(d) mutation in TLR4, which renders mice insensitive to LPS. However, a putative salt bridge typically found in TIR domains appears to be dispensable. We further identified a C-terminal domain required for activation of C/EBPbeta and induction of a subset IL-17 target genes. This structure-function analysis of a IL-17 superfamily receptor reveals important differences in IL-17RA compared with IL-1/TLR receptors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17456598      PMCID: PMC1863505          DOI: 10.1073/pnas.0611589104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  61 in total

1.  CD40 signaling through tumor necrosis factor receptor-associated factors (TRAFs). Binding site specificity and activation of downstream pathways by distinct TRAFs.

Authors:  S S Pullen; T T Dang; J J Crute; M R Kehry
Journal:  J Biol Chem       Date:  1999-05-14       Impact factor: 5.157

2.  Interleukin-17/interleukin-17 receptor-mediated signaling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection.

Authors:  Michelle N Kelly; Jay K Kolls; Kyle Happel; Joseph D Schwartzman; Paul Schwarzenberger; Crescent Combe; Magali Moretto; Imtiaz A Khan
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

3.  Severe CD4 T cell-mediated immunopathology in murine schistosomiasis is dependent on IL-12p40 and correlates with high levels of IL-17.

Authors:  Laura I Rutitzky; Jessica R Lopes da Rosa; Miguel J Stadecker
Journal:  J Immunol       Date:  2005-09-15       Impact factor: 5.422

4.  Cytokines link osteoblasts and inflammation: microarray analysis of interleukin-17- and TNF-alpha-induced genes in bone cells.

Authors:  Fang Shen; Matthew J Ruddy; Pascale Plamondon; Sarah L Gaffen
Journal:  J Leukoc Biol       Date:  2004-12-10       Impact factor: 4.962

5.  Sequential phosphorylation of CCAAT enhancer-binding protein beta by MAPK and glycogen synthase kinase 3beta is required for adipogenesis.

Authors:  Qi-Qun Tang; Mads Grønborg; Haiyan Huang; Jae-Woo Kim; Tamara C Otto; Akhilesh Pandey; M Daniel Lane
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-28       Impact factor: 11.205

Review 6.  Neutrophils, interleukin-17A and lung disease.

Authors:  A Lindén; M Laan; G P Anderson
Journal:  Eur Respir J       Date:  2005-01       Impact factor: 16.671

7.  Interleukin-17 regulates expression of the CXC chemokine LIX/CXCL5 in osteoblasts: implications for inflammation and neutrophil recruitment.

Authors:  Matthew J Ruddy; Fang Shen; Jeffrey B Smith; Ashu Sharma; Sarah L Gaffen
Journal:  J Leukoc Biol       Date:  2004-04-23       Impact factor: 4.962

8.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.

Authors:  A Poltorak; X He; I Smirnova; M Y Liu; C Van Huffel; X Du; D Birdwell; E Alejos; M Silva; C Galanos; M Freudenberg; P Ricciardi-Castagnoli; B Layton; B Beutler
Journal:  Science       Date:  1998-12-11       Impact factor: 47.728

9.  IL-23 drives a pathogenic T cell population that induces autoimmune inflammation.

Authors:  Claire L Langrish; Yi Chen; Wendy M Blumenschein; Jeanine Mattson; Beth Basham; Jonathan D Sedgwick; Terrill McClanahan; Robert A Kastelein; Daniel J Cua
Journal:  J Exp Med       Date:  2005-01-17       Impact factor: 14.307

Review 10.  The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models.

Authors:  Erik Lubberts; Marije I Koenders; Wim B van den Berg
Journal:  Arthritis Res Ther       Date:  2004-11-30       Impact factor: 5.156

View more
  81 in total

Review 1.  Cytokine regulation of B-cell migratory behavior favors formation of germinal centers in autoimmune disease.

Authors:  John D Mountz; John H Wang; Shutao Xie; Hui-Chen Hsu
Journal:  Discov Med       Date:  2011-01       Impact factor: 2.970

2.  SEF/IL-17R (SEFIR) is not enough: an extended SEFIR domain is required for il-17RA-mediated signal transduction.

Authors:  Reiko M Onishi; Sangmi J Park; Walter Hanel; Allen W Ho; Amarnath Maitra; Sarah L Gaffen
Journal:  J Biol Chem       Date:  2010-08-20       Impact factor: 5.157

3.  CCAAT/Enhancer-binding protein β promotes pathogenesis of EAE.

Authors:  Michelle R Simpson-Abelson; Gerard Hernandez-Mir; Erin E Childs; J Agustin Cruz; Amanda C Poholek; Ansuman Chattopadhyay; Sarah L Gaffen; Mandy J McGeachy
Journal:  Cytokine       Date:  2017-01-12       Impact factor: 3.861

4.  Cutting edge: identification of a pre-ligand assembly domain (PLAD) and ligand binding site in the IL-17 receptor.

Authors:  Jill M Kramer; Walter Hanel; Fang Shen; Nilgun Isik; James P Malone; Amarnath Maitra; Wade Sigurdson; David Swart; Joel Tocker; Tian Jin; Sarah L Gaffen
Journal:  J Immunol       Date:  2007-11-15       Impact factor: 5.422

Review 5.  Toll-like receptors in tumor immunotherapy.

Authors:  Chrystal M Paulos; Andrew Kaiser; Claudia Wrzesinski; Christian S Hinrichs; Lydie Cassard; Andrea Boni; Pawel Muranski; Luis Sanchez-Perez; Douglas C Palmer; Zhiya Yu; Paul A Antony; Luca Gattinoni; Steven A Rosenberg; Nicholas P Restifo
Journal:  Clin Cancer Res       Date:  2007-09-15       Impact factor: 12.531

Review 6.  Structure-function relationships in the IL-17 receptor: implications for signal transduction and therapy.

Authors:  Fang Shen; Sarah L Gaffen
Journal:  Cytokine       Date:  2008-01-04       Impact factor: 3.861

Review 7.  IL-17 family: cytokines, receptors and signaling.

Authors:  Chunfang Gu; Ling Wu; Xiaoxia Li
Journal:  Cytokine       Date:  2013-09-03       Impact factor: 3.861

Review 8.  A tale of two cytokines: IL-17 and IL-22 in asthma and infection.

Authors:  Michelle L Manni; Keven M Robinson; John F Alcorn
Journal:  Expert Rev Respir Med       Date:  2013-12-10       Impact factor: 3.772

Review 9.  IL-17RC: a partner in IL-17 signaling and beyond.

Authors:  Allen W Ho; Sarah L Gaffen
Journal:  Semin Immunopathol       Date:  2009-12-13       Impact factor: 9.623

10.  Interplay between effector Th17 and regulatory T cells.

Authors:  Amit Awasthi; Gopal Murugaiyan; Vijay K Kuchroo
Journal:  J Clin Immunol       Date:  2008-09-23       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.